Suzhen Chen1,2, Yuqun Zhang3, Yonggui Yuan1,2. 1. Department of Psychosomatics and Psychiatry, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, 210009, People's Republic of China. 2. Institute of Psychosomatics, School of Medicine, Southeast University, Nanjing, 210009, People's Republic of China. 3. School of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
Abstract
PURPOSE: Misdiagnosis and ineffective treatment are common in major depressive disorder (MDD) in current clinical practice, while the combination of various serum proteins may assist the correct diagnosis. The study aimed to explore whether the combination of serum inflammatory, stress, and neurotrophic factors could be helpful for the diagnosis of MDD and to investigate the predictors associated with early symptom improvements. PATIENTS AND METHODS: Baseline serum levels of C-reactive protein (CRP), interleukin (IL)-6, IL-10, IL-1beta, tumor necrosis factor (TNF)-alpha, interferon (INF)-gamma, cortisol, and brain-derived neurotrophic factor (BDNF) were detected in 30 MDD patients and 30 age- and gender-matched healthy controls. 17-item Hamilton Depression Rating Scale (HAMD-17) and Hamilton Anxiety Rating Scale (HAMA) were applied to assess symptoms both at baseline and two weeks after antidepressant treatment. Stepwise multiple linear regression was employed to identify the early efficacy predictors, and a logistic regression model was built with the above serum proteins. The area under the receiver operating characteristic (AUC) curve was calculated to evaluate the model's diagnostic power. RESULTS: Multiple linear regression revealed that baseline scores of retardation (β = -0.432, P = 0.012) and psychological anxiety (β = -0.423, P = 0.014) factors were negatively associated with the reduction rate of HAMD-17. A simple and efficient diagnostic model using serum BDNF, cortisol, and IFN-gamma levels was established by the forward stepwise logistic regression, and the model achieved an AUC of 0.884, with 86.7% sensitivity and 83.3% specificity. CONCLUSION: The results showed that combining serum BDNF, cortisol and IFN-gamma could aid the diagnosis of MDD, while baseline retardation and psychological anxiety may predict the poor early symptom improvement.
PURPOSE: Misdiagnosis and ineffective treatment are common in major depressive disorder (MDD) in current clinical practice, while the combination of various serum proteins may assist the correct diagnosis. The study aimed to explore whether the combination of serum inflammatory, stress, and neurotrophic factors could be helpful for the diagnosis of MDD and to investigate the predictors associated with early symptom improvements. PATIENTS AND METHODS: Baseline serum levels of C-reactive protein (CRP), interleukin (IL)-6, IL-10, IL-1beta, tumor necrosis factor (TNF)-alpha, interferon (INF)-gamma, cortisol, and brain-derived neurotrophic factor (BDNF) were detected in 30 MDD patients and 30 age- and gender-matched healthy controls. 17-item Hamilton Depression Rating Scale (HAMD-17) and Hamilton Anxiety Rating Scale (HAMA) were applied to assess symptoms both at baseline and two weeks after antidepressant treatment. Stepwise multiple linear regression was employed to identify the early efficacy predictors, and a logistic regression model was built with the above serum proteins. The area under the receiver operating characteristic (AUC) curve was calculated to evaluate the model's diagnostic power. RESULTS: Multiple linear regression revealed that baseline scores of retardation (β = -0.432, P = 0.012) and psychological anxiety (β = -0.423, P = 0.014) factors were negatively associated with the reduction rate of HAMD-17. A simple and efficient diagnostic model using serum BDNF, cortisol, and IFN-gamma levels was established by the forward stepwise logistic regression, and the model achieved an AUC of 0.884, with 86.7% sensitivity and 83.3% specificity. CONCLUSION: The results showed that combining serum BDNF, cortisol and IFN-gamma could aid the diagnosis of MDD, while baseline retardation and psychological anxiety may predict the poor early symptom improvement.
Authors: O Troyanskaya; M Cantor; G Sherlock; P Brown; T Hastie; R Tibshirani; D Botstein; R B Altman Journal: Bioinformatics Date: 2001-06 Impact factor: 6.937
Authors: Willemijn T C J Heijnen; Astrid M Kamperman; Lindsay D Tjokrodipo; Witte J G Hoogendijk; Walter W van den Broek; Tom K Birkenhager Journal: J Psychiatr Res Date: 2018-11-15 Impact factor: 4.791
Authors: Frieder Haenisch; Jason D Cooper; Andreas Reif; Sarah Kittel-Schneider; Johann Steiner; F Markus Leweke; Matthias Rothermundt; Nico J M van Beveren; Benedicto Crespo-Facorro; David W Niebuhr; David N Cowan; Natalya S Weber; Robert H Yolken; Brenda W J H Penninx; Sabine Bahn Journal: Brain Behav Immun Date: 2015-10-13 Impact factor: 7.217
Authors: Linda van Diermen; Simon Vanmarcke; Sebastian Walther; Herman Moens; Eveline Veltman; Erik Fransen; Bernard Sabbe; Roos van der Mast; Tom Birkenhäger; Didier Schrijvers Journal: J Psychiatr Res Date: 2019-07-29 Impact factor: 4.791
Authors: Christine L Parr; Anette Hjartåker; Ida Scheel; Eiliv Lund; Petter Laake; Marit B Veierød Journal: Public Health Nutr Date: 2007-07-02 Impact factor: 4.022